Genovis AB (publ.) Past Earnings Performance
Past criteria checks 2/6
Genovis AB (publ.) has been growing earnings at an average annual rate of 47.8%, while the Life Sciences industry saw earnings growing at 19.6% annually. Revenues have been growing at an average rate of 25.9% per year. Genovis AB (publ.)'s return on equity is 15%, and it has net margins of 24%.
Key information
47.8%
Earnings growth rate
47.4%
EPS growth rate
Life Sciences Industry Growth | 26.8% |
Revenue growth rate | 25.9% |
Return on equity | 15.0% |
Net Margin | 24.0% |
Next Earnings Update | 20 Aug 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Genovis AB (publ.) makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Mar 24 | 128 | 31 | 77 | 0 |
31 Dec 23 | 159 | 62 | 79 | 0 |
30 Sep 23 | 158 | 54 | 78 | 0 |
30 Jun 23 | 151 | 57 | 76 | 0 |
31 Mar 23 | 142 | 42 | 73 | 0 |
31 Dec 22 | 104 | 11 | 68 | 0 |
30 Sep 22 | 119 | 41 | 64 | 0 |
30 Jun 22 | 112 | 36 | 60 | 0 |
31 Mar 22 | 111 | 36 | 57 | 0 |
31 Dec 21 | 94 | 25 | 53 | 0 |
30 Sep 21 | 71 | 11 | 52 | 0 |
30 Jun 21 | 69 | 12 | 51 | 0 |
31 Mar 21 | 65 | 9 | 50 | 0 |
31 Dec 20 | 61 | 6 | 47 | 0 |
30 Sep 20 | 54 | -3 | 46 | 0 |
30 Jun 20 | 64 | 3 | 43 | 0 |
31 Mar 20 | 60 | 6 | 41 | 0 |
31 Dec 19 | 61 | 10 | 39 | 0 |
30 Sep 19 | 58 | 12 | 36 | 0 |
30 Jun 19 | 43 | 5 | 33 | 0 |
31 Mar 19 | 40 | 1 | 32 | 0 |
31 Dec 18 | 35 | -2 | 30 | 0 |
30 Sep 18 | 31 | -4 | 29 | 0 |
30 Jun 18 | 27 | -6 | 28 | 0 |
31 Mar 18 | 24 | -7 | 28 | 0 |
31 Dec 17 | 23 | -8 | 28 | 0 |
30 Sep 17 | 21 | -9 | 28 | 0 |
30 Jun 17 | 21 | -9 | 27 | 0 |
31 Mar 17 | 20 | -14 | 31 | 0 |
31 Dec 16 | 19 | -15 | 37 | 0 |
30 Sep 16 | 17 | -16 | 39 | 0 |
30 Jun 16 | 16 | -21 | 42 | 0 |
31 Mar 16 | 14 | -18 | 40 | 0 |
31 Dec 15 | 14 | -20 | 35 | 0 |
30 Sep 15 | 13 | -25 | 41 | 0 |
30 Jun 15 | 11 | -24 | 36 | 0 |
31 Mar 15 | 10 | -23 | 30 | 0 |
31 Dec 14 | 10 | -22 | 26 | 0 |
30 Sep 14 | 8 | -20 | 24 | 0 |
30 Jun 14 | 10 | -17 | 24 | 0 |
31 Mar 14 | 11 | -16 | 23 | 0 |
31 Dec 13 | 10 | -16 | 23 | 0 |
30 Sep 13 | 10 | -19 | 21 | 0 |
30 Jun 13 | 9 | -19 | 21 | 0 |
Quality Earnings: 5GV has high quality earnings.
Growing Profit Margin: 5GV's current net profit margins (24%) are lower than last year (29.8%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 5GV's earnings have grown significantly by 47.8% per year over the past 5 years.
Accelerating Growth: 5GV's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 5GV had negative earnings growth (-27.7%) over the past year, making it difficult to compare to the Life Sciences industry average (-1.7%).
Return on Equity
High ROE: 5GV's Return on Equity (15%) is considered low.